Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise

About Noven

Overview

Noven Doctor

Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. We are committed to developing and offering pharmaceutical products that meaningfully benefit patients, with a commitment to advancing patient care through transdermal drug delivery.

Over 325 Noven colleagues are working to advance our business and benefit patients at locations in Miami, FL and New York, NY. We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches, and we serve as Hisamitsu's platform for U.S. prescription pharmaceuticals, helping Hisamitsu bring the benefits of patch therapy to the world.

Noven Coater

Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances.

Noven’s commercialized transdermal products include Minivelle® (estradiol transdermal system), the planet’s smallest estrogen patch; CombiPatch® (estradiol/norethindrone acetate transdermal system), the first approved combination (two-drug) patch; Daytrana® (methylphenidate transdermal system), the first and only patch approved for the treatment of ADHD. For more information on our products, click here.

Minivelle Patch

Noven’s product development pipeline includes a range of prescription transdermal products that utilize Noven’s advanced transdermal delivery technology. For a summary of our disclosed pipeline, click here.

Fast Facts

Core Business:

Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.

Year of Incorporation:

1987

Employees:

Over 325

Chief Executive Officer:

Jeff Mihm

Media, General Business
& Other Inquiries:

Tel: 305-253-1916
CorporateAffairs@noven.com

Partnering and Other Business Development Opportunities

Tel: 212-287-0988
BusDev@noven.com

Physican Payment
Sunshine Act Inquiries:

Aggspend@noven.com

Employment Inquiries:

Rory Kelly
Manager – Recruiting
Tel: 305-964-3588
Careers Page

Community Support:

Corporate Social Responsibility

Affiliated Companies:

Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.